NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/24/2023
Back to search
Official data from USPTO
BENIVEX PHARMACY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BENIVEX PHARMACY
ST13
US500000090621001Class
35, 44
Filing
90621001
Registration
7198474
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
10/24/2023
Trademark type
Word
Nice classes
35, 44
Filing date
04/02/2021
Registration date
10/24/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/24/2023
Last transaction
10/24/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/14/2015
First use in commerce
05/14/2015
Drawing code
4
Owner type
03
Owner location
Aurora, IL
Examiner
DANG, PETER
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Benivex, Inc.
Representatives
Thomas S. Key BLAISE & NITSCHKE, P.C.
Technical classification
Nice Classes
Class 35Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Pharmaceutical servicesprocessing online and telephone prescription orders in retail and central fill pharmacies; Retail store services for pharmaceuticalveterinary and sanitary preparations and medical supplies
Class 44
Medical testing for diagnostic or treatment purposes; Medication counseling; Pharmaceutical advice; Pharmaceutical compounding services; Preparation of prescriptions by pharmacists; Preparation of prescriptions in pharmacies
Publications
History of USPTO decisions and trademark events.
34 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/24/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/08/2023
PUBO
PUBLISHED FOR OPPOSITION
08/08/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/19/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/05/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
07/05/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/05/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
07/05/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/05/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/14/2023
GNRT
NON-FINAL ACTION E-MAILED
03/14/2023
CNRT
NON-FINAL ACTION WRITTEN
03/14/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/08/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/08/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/08/2022
GNRT
NON-FINAL ACTION E-MAILED
12/08/2022
CNRT
NON-FINAL ACTION WRITTEN
12/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/19/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/18/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/18/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/20/2022
GNFR
FINAL REFUSAL E-MAILED
05/20/2022
CNFR
FINAL REFUSAL WRITTEN
05/20/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/19/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/18/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/18/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/18/2021
GNRT
NON-FINAL ACTION E-MAILED
11/18/2021
CNRT
NON-FINAL ACTION WRITTEN
11/18/2021
DOCK
ASSIGNED TO EXAMINER
11/17/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/11/2021
NWAP
NEW APPLICATION ENTERED
04/06/2021
Continuous trademark protection
Get notified about every new filing that threatens BENIVEX PHARMACY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.